Merit Medical Systems, Inc. $MMSI Shares Sold by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH lessened its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 22.3% in the third quarter, Holdings Channel reports. The institutional investor owned 369,895 shares of the medical instruments supplier’s stock after selling 106,253 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Merit Medical Systems were worth $31,896,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of MMSI. GAMMA Investing LLC lifted its holdings in shares of Merit Medical Systems by 9.2% in the third quarter. GAMMA Investing LLC now owns 3,550 shares of the medical instruments supplier’s stock worth $306,000 after buying an additional 300 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Merit Medical Systems by 44.0% in the third quarter. Farther Finance Advisors LLC now owns 890 shares of the medical instruments supplier’s stock valued at $77,000 after acquiring an additional 272 shares during the period. Congress Asset Management Co. boosted its position in shares of Merit Medical Systems by 6.4% in the third quarter. Congress Asset Management Co. now owns 1,260,675 shares of the medical instruments supplier’s stock valued at $108,708,000 after acquiring an additional 76,338 shares during the period. Moody National Bank Trust Division bought a new position in shares of Merit Medical Systems in the third quarter valued at approximately $203,000. Finally, QRG Capital Management Inc. grew its stake in Merit Medical Systems by 10.9% during the second quarter. QRG Capital Management Inc. now owns 9,305 shares of the medical instruments supplier’s stock valued at $645,000 after acquiring an additional 917 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on MMSI. JPMorgan Chase & Co. boosted their price objective on shares of Merit Medical Systems from $77.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Wells Fargo & Company increased their target price on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Canaccord Genuity Group increased their target price on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Bank of America raised their price target on shares of Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Finally, Barrington Research set a $114.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Merit Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $100.00.

Merit Medical Systems Stock Performance

NASDAQ:MMSI opened at $89.57 on Friday. The business’s 50-day moving average price is $88.30 and its two-hundred day moving average price is $75.88. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.75. The stock has a market cap of $5.35 billion, a P/E ratio of 23.75, a PEG ratio of 2.18 and a beta of 0.51. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%. The firm had revenue of $418.84 million during the quarter, compared to the consensus estimate of $405.25 million. During the same quarter last year, the company posted $1.01 EPS. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities analysts predict that Merit Medical Systems, Inc. will post 3.84 EPS for the current fiscal year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a medical device company that develops, manufactures and markets disposable products used in interventional, diagnostic and therapeutic procedures. Its devices are designed for use by healthcare professionals in areas including cardiology, radiology, oncology, vascular intervention, gastroenterology and other specialty fields.

The company’s product portfolio includes devices for accessing the vasculature, controlling and managing fluids, performing biopsies, treating peripheral vascular disease, delivering embolic therapies, and supporting drainage and intervention procedures.